Description
Gene Therapy, Cell Therapy, Regulatory Consulting Firm
Los Angeles, CA (Relocatable)
Asking Price: Best Possible Offer
Cash Flow: $1,144,000
Revenue: $2,989,000
EBITDA: $1,144,000
FF&E: N/A
Inventory: N/A
Established: 2011
Employees: 1
Business Description:
Founded in 2011, the Company is a niche consulting and advisory firm serving in cell therapy, gene and gene-modified cell therapies, other regenerative medicines, tissue engineering, and cell-based drug discovery. The company’s core focus is to improve cell & gene therapy innovations by providing consulting services for improving business strategy and achieving major regulatory milestones for companies.
The Company has created a one-stop shop for all aspects of cell therapy and gene therapy, including quality checks, regulatory meetings, and submissions with the help of leading experts worldwide. The leadership has a unique combination of experience in the academic, biotech industry, government/FDA, and consulting.
They serve biotech, pharma companies, consulting services for healthcare providers, subcontracts for other consulting firms, and contracts with government organizations, which enables them to have 6x+ growth in net income from 2019–2021, i.e., $179,000 to $1,095,000 with the help of 110+ customers served over the past six years.
The Company’s plan is to consummate a transaction with a supportive growth partner in order to accelerate the company’s cell and gene therapy market growth by interacting with industry, academia, government, and other international stakeholders in cell & gene therapies and cell-based drug discovery. NDA is required {SUBMIT BELOW} to secure comprehensive Confidential Information Memorandum (CIM) crafted by ProNova Partners.
Detailed Information
Facilities:
Has headquarters in US – contractors operate nationwide / portable / buyer can be located worldwide.
Competition:
A few competitors in the space are in the field but the Company provides best in class services for its respective niche(s).
Growth & Expansion:
Continually grow and become more profitable with the help of experts that supports preclinical, clinical, and commercial advisory in the manufacturing, regulatory affairs, Quality/GxP, and M&A arenas.
Financing:
If the price and deal structure is right.
Support & Training:
Long term transition, Seller wishes to smooth the transition to maximize success with the
Company post-closing and spearhead continued growth.
Reason for Selling:
Growth.
ProNova Partners Buyer Profile & NDA
***RED STARS ARE REQUIRED FIELDS***
This information is required and must be filled in completely before the Seller will release any vital information, including business address, financial due diligence package on file, and other sensitive confidential information.
It will also be used by ProNova Partners to match your buyer profile with future similar engagements our firm has for sale.
* Required
function validateCaptcha()
{
var web_set_captcha = 'No';
web_set_captcha = document.getElementById('web_set_captcha').value;
if(web_set_captcha == 'Yes')
{
var googleResponse = $('#g-recaptcha-response').val();
if (!googleResponse) {
$('
Please Validate Captcha.
').insertAfter("#captcha_element");
return false;
} else
return true;
}
else
return true;
}